Teva Pharmaceutical Industries Ltd (TEVA)

2,960
+10(+0.34%)
  • Volume:
    5,164,539
  • Bid/Ask:
    2,951/2,960
  • Day's Range:
    2,931 - 3,000
Unusual trading volume

Teva has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

TEVA Overview

Prev. Close
2,950
Day's Range
2,931-3,000
Revenue
47.31B
Open
3,000
52 wk Range
2,383-3,723
EPS
-1.17
Volume
5,164,539
Market Cap
32.78B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,604,473
P/E Ratio
-7.66
Beta
1.27
1-Year Change
10.45%
Shares Outstanding
1,110,644,809
Next Earnings Date
15 Feb 2023
What is your sentiment on Teva?
or
Market is currently closed. Voting is open during market hours.

Teva Pharmaceutical Industries Ltd News

Teva Pharmaceutical Industries Ltd Company Profile

Teva Pharmaceutical Industries Ltd Company Profile

Employees
35346
Market
Israel
  • Type:Equity
  • Market:Israel
  • ISIN:IL0006290147
  • S/N:629014

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company’s products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellSell